Afibrinogenemia
Showing 1 - 19 of 19
Congenital Afibrinogenemia Trial in Worldwide (Human Plasma-Derived Fibrinogen Concentrate)
Completed
- Congenital Afibrinogenemia
- Human Plasma-Derived Fibrinogen Concentrate
-
New Hyde Park, New York
- +5 more
Mar 22, 2022
First Trimester Abortion, Surgical Abortion, Miscarriage With Afibrinogenemia Trial (MateRegen® gel (BioRegen))
Recruiting
- First Trimester Abortion
- +2 more
- MateRegen® gel (BioRegen)
-
Hong Kong, Hong KongThe Chinese University of Hong Kong
Oct 30, 2022
Fibryga in Congenital Fibrinogen Deficiency
Recruiting
- Congenital Fibrinogen Deficiency
- Fibryga
-
Frankfurt, Germany
- +1 more
Jan 31, 2023
Identify Patients With Complement Factor I Deficiencies
Terminated
- Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I Deficiency
-
Huntsville, AlabamaNephrology Consultants, LLC
Mar 31, 2022
Congenital Afibrinogenemia, Hypofibrinogenemia Trial in Worldwide (FIB Grifols)
Suspended
- Congenital Afibrinogenemia
- Hypofibrinogenemia
- FIB Grifols
-
New Hyde Park, New York
- +9 more
May 11, 2021
Quality of Life in Patients With Congenital Afibrinogenemia
Completed
- Afibrinogenemia, Congenital
- Questionnaire quality of life
-
Orange, California
- +27 more
Nov 10, 2020
Congenital Fibrinogen Deficiency Trial in India, Iran, Islamic Republic of, Lebanon (Octafibrin)
Completed
- Congenital Fibrinogen Deficiency
- Octafibrin
-
Bangalore, India
- +3 more
Dec 21, 2020
Congenital Fibrinogen Deficiency Trial in Worldwide (Octafibrin)
Completed
- Congenital Fibrinogen Deficiency
-
Miami, Florida
- +11 more
Dec 21, 2020
Fibrinogen Plasma Levels After Fibrinogen Administration
Completed
- Fibrinogen; Deficiency, Acquired
- PHARMACOKINETICS
- DATA RECORDING
-
Barcelona, Spain
- +1 more
Aug 12, 2022
Fibrinogen Concentrate Administration on Biological Parameters
Completed
- Hemorrhage
- (no location specified)
Feb 26, 2020
Congenital Fibrinogen Deficiency, Afibrinogenemia Trial in Worldwide (Octafibrin, Haemocomplettan® P or RiaSTAPTM)
Completed
- Congenital Fibrinogen Deficiency
- Afibrinogenemia
- Octafibrin
- Haemocomplettan® P or RiaSTAPTM
-
Aurora, Colorado
- +9 more
Mar 6, 2018
Fibrinogen Concentrate, Human in Congenital Fibrinogen
Completed
- Congenital Fibrinogen Deficiency
- FCH
-
Aurora, Colorado
- +10 more
Jan 12, 2018
Fibrinogen Deficiency Trial in Italy, United States (Human Fibrinogen Concentrate)
Completed
- Fibrinogen Deficiency
- Human Fibrinogen Concentrate
-
Aurora, Colorado
- +14 more
Jul 27, 2016
Hypofibrinogenemia, Congenital, Afibrinogenemia, Congenital Trial in Worldwide (biological: human fibrinogen concentrate)
Completed
- Hypofibrinogenemia, Congenital
- Afibrinogenemia, Congenital
- biological: human fibrinogen concentrate
-
Paris, France
- +3 more
Feb 11, 2016
Heart Valve Disease, Coronary Artery Disease Trial in Atlanta (Human fibrinogen concentrate, apheresis platelets)
Terminated
- Heart Valve Disease
- Coronary Artery Disease
- Human fibrinogen concentrate
- apheresis platelets
-
Atlanta, GeorgiaEmory University Hospital
May 23, 2018
Fibrinogen Deficiency in Complex Cardiac Surgery Trial in Zwolle (Haemocomplettan® P, Human albumin (Placebo))
Completed
- Fibrinogen Deficiency in Complex Cardiac Surgery
- Haemocomplettan® P
- Human albumin (Placebo)
-
Zwolle, Overijssel, Netherlands
- +1 more
Dec 15, 2014
Afibrinogenemia, Hypofibrinogenemia, Fibrinogen Deficiency Trial (Fibrinogen Concentrate, Human (FCH), Cryoprecipitate)
Withdrawn
- Afibrinogenemia
- +2 more
- Fibrinogen Concentrate, Human (FCH)
- Cryoprecipitate
- (no location specified)
May 6, 2014
Coagulopathic Bleeding Trial in Durham (RiaSTAP)
Completed
- Coagulopathic Bleeding
-
Durham, North CarolinaDuke University Medical Center
Dec 5, 2014